2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.

{"article_title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.","author":"","journal_title":"Atherosclerosis","issn":"1879-1484","isbn":"","publication_date":"2019-11-01","volume":"290","issue":"","first_page":"140","page_count":"","accession_number":"31591002","doi":"10.1016\/j.atherosclerosis.2019.08.014","publisher":"Elsevier","doctype":"Journal Article","subjects":"Cardiovascular Diseases prevention & control; Dyslipidemias drug therapy; Hypolipidemic Agents therapeutic use; Lipids blood; Adult; Aged; Biomarkers blood; Cardiovascular Diseases diagnosis; Cardiovascular Diseases epidemiology; Consensus; Drug Therapy, Combination; Dyslipidemias blood; Dyslipidemias diagnosis; Dyslipidemias epidemiology; Female; Humans; Hypolipidemic Agents adverse effects; Male; Middle Aged; Risk Assessment; Risk Factors; Risk Reduction Behavior; Treatment Outcome","interest_area":["Cardiology"," Internal Medicine"],"abstract":"","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=31591002","isPdfLink":false,"isSAML":true,"an":"31591002","number_other":"","type_pub":"","issn_electronic":"1879-1484","languages":"English","language":"eng","date_entry":"Date Created: 20191009 Date Completed: 20200803 Latest Revision: 20200803","date_update":"20240104","titleSource":"Atherosclerosis [Atherosclerosis] 2019 Nov; Vol. 290, pp. 140-205. Date of Electronic Publication: 2019 Aug 31.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2019-11-01","upload_link":"https:\/\/dx.doi.org\/doi:10.1016\/j.atherosclerosis.2019.08.014","no_of_pages":"","authored_by":"Authors\/Task Force Members, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies","additionalInfo":{"Corporate_Authors":"Authors\/Task Force Members, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies","Journal_Info":"Publisher: Elsevier Country of Publication: Ireland NLM ID: 0242543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1484 (Electronic) Linking ISSN: 00219150 NLM ISO Abbreviation: Atherosclerosis Subsets: MEDLINE","Publication_Type":"Journal Article; Practice Guideline; Review","Published_Date":"2019-11-01","Source":"Atherosclerosis [Atherosclerosis] 2019 Nov; Vol. 290, pp. 140-205. Date of Electronic Publication: 2019 Aug 31.","Languages":"English","Electronic_ISSN":"1879-1484","MeSH_Terms":"Cardiovascular Diseases\/*prevention & control , Dyslipidemias\/*drug therapy , Hypolipidemic Agents\/*therapeutic use , Lipids\/*blood, Adult ; Aged ; Biomarkers\/blood ; Cardiovascular Diseases\/diagnosis ; Cardiovascular Diseases\/epidemiology ; Consensus ; Drug Therapy, Combination ; Dyslipidemias\/blood ; Dyslipidemias\/diagnosis ; Dyslipidemias\/epidemiology ; Female ; Humans ; Hypolipidemic Agents\/adverse effects ; Male ; Middle Aged ; Risk Assessment ; Risk Factors ; Risk Reduction Behavior ; Treatment Outcome","Subjects":"Adult, Aged, Biomarkers blood, Cardiovascular Diseases diagnosis, Cardiovascular Diseases epidemiology, Consensus, Drug Therapy, Combination, Dyslipidemias blood, Dyslipidemias diagnosis, Dyslipidemias epidemiology, Female, Humans, Hypolipidemic Agents adverse effects, Male, Middle Aged, Risk Assessment, Risk Factors, Risk Reduction Behavior, Treatment Outcome, Cardiovascular Diseases prevention & control, Dyslipidemias drug therapy, Hypolipidemic Agents therapeutic use, Lipids blood","Title_Abbreviations":"Atherosclerosis","Volume":"290"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"31591002","RelevancyScore":"776","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"776.149963378906"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=31591002&authtype=shib&custid=ns346513&group=main&profile=eds"}